It includes:
This information is for educational purposes. Individuals suffering from any malady or its effects should seek the care of a medical professional. The statements contained on this page have not been reviewed by the FDA. Do not take if pregnant
in conjunction with Chemo and Radiation
Some in the oncology community contend that patients undergoing chemotherapy – radiation therapy should not use antioxidants and other nutrients. Oncologists contended, antioxidants interfere with radiation and some chemotherapies, and that folic acid interferes with methotrexate. This is despite the common use of amifostine and dexrazoxane, 2 prescription antioxidants, during chemotherapy and/or radiation therapy.
To assess all evidence concerning antioxidant and other nutrients used concomitantly with chemotherapy and/or radiation therapy. The MEDLINE® and CANCERLIT® databases were searched from 1965 to November 2003 using the words vitamins, antioxidants, chemotherapy, and radiation therapy. Bibliographies of articles were searched. All studies reporting concomitant nutrient use with chemotherapy and/or radiation therapy (280 peer-reviewed articles including 62 in vitro and 218 in vivo) were indiscriminately included.
Fifty human clinical randomized or observational trials have been conducted, involving 8,521 patients using beta-carotene; vitamins A, C, and E; selenium; cysteine; B vitamins; vitamin D3; vitamin K3; and glutathione as single agents or in combination.
Since the 1970s, 468 peer-reviewed in vitro and in vivo studies, including 91 human studies involving 12,991 patients, 7,181 of whom were given nutrients, have consistently shown that they do not interfere with therapeutic modalities for cancer. Furthermore, non-prescription antioxidants and other nutrients enhance the killing of therapeutic modalities for cancer, decrease their side effects, and protect normal tissue.
In 26 human studies,5,238 patients who took non-prescription antioxidants and other nutrients actually had increased survival.
Charles B. Simone II, MD, and Nicole L. Simone, MD, are consulting physicians, Victoria Simone, RN, is a research nurse, and Charles B. Simone, MD, is a consulting physician and medical director, all at the Simone Protective Cancer Institute in Lawrenceville, NJ.
Altern Ther Health Med. 2007;13(2):40-46.
Conclusion, 468 peer-reviewed in vitro and in vivo studies, including 91 human studies involving 12,991 patients, 7,181 of whom were given nutrients, have consistently shown that they do not interfere with therapeutic modalities for cancer. Furthermore, non-prescription antioxidants and other nutrients enhance the killing of therapeutic modalities for cancer, decrease their side effects, and protect normal tissue.
In 26 human studies, 5,238 patients who took non-prescription antioxidants and other nutrients actually had increased survival.
Patients who are undergoing active therapy, recovering, or in remission and striving to avoid cancer recurrence, the benefit of optimal caloric and nutrient intake is well documented.
The goals of nutrition therapy are to accomplish the following:
